MicroRNA-145 Regulates Chondrogenic Differentiation of Mesenchymal Stem Cells by Targeting Sox9
2011

MicroRNA-145 and Chondrogenic Differentiation of Stem Cells

publication Evidence: moderate

Author Information

Author(s): Yang Bo, Guo Hongfeng, Zhang Yulan, Chen Lei, Ying Dajun, Dong Shiwu

Primary Institution: Laboratory of Biomechanics, Department of Anatomy, The Third Military Medical University, Chongqing, People's Republic of China

Hypothesis

MiR-145 inhibits chondrogenic differentiation of mesenchymal stem cells by targeting Sox9.

Conclusion

MiR-145 acts as a key negative regulator of chondrogenic differentiation by directly targeting Sox9.

Supporting Evidence

  • MiR-145 expression decreases during TGF-β3-induced chondrogenic differentiation.
  • Over-expression of miR-145 inhibits Sox9 protein levels.
  • Inhibition of miR-145 enhances the expression of chondrogenic marker genes.

Takeaway

This study found that a tiny molecule called miR-145 can stop stem cells from turning into cartilage cells by blocking a protein called Sox9.

Methodology

The study used qRT-PCR, dual-luciferase reporter assays, and Western blot analysis to investigate the role of miR-145 in chondrogenic differentiation.

Limitations

The effects of miR-145 on terminal differentiation of chondrogenesis were not fully explored beyond 14 days.

Participant Demographics

Murine mesenchymal stem cells were used in the study.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0021679

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication